![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Saturday, May 12, 2018 6:42:38 AM
I asked....
"Do the purported "constant short and distort attacks" explain why the share price continued downward in spite of today's press release?" on the day that IPIX reported some results on the efficacy of B-OM, asserting that "The commercial potential for Brilacidin-OM in HNC is substantial and untapped".
It wasn't "a strategic attempt to influence perception by disseminating negative and dubious or false information". It was a serious question about what seemed to be a counter-intuitive market response to good news.
Yesterday's market response seemed similarly counter-intuitive. The Balance Sheet and some of the text in the 10-Q addressed some fairly serious questions about the company's liquidity and one of its drugs yet the share price moved up a bit.
Some may have liked the filing overall, but...
The S-3 issue was raised in some detail, is complicated and still open in at least one critical respect, but this simple non-scientist couldn't help but notice that there was a change in presentation involving Prurisol that may speak to the company's actual assessment of it even in the purported absence of data.
The 12/31 10-Q Clinical Development Programs Section lists the company's compounds like this:
Prurisol
Brilacidin
Kevetrin
The same Section in yesterday's 10-Q lists them like this:
Brilacidin
Kevetrin
Prurisol
I'm not making any BIG claim about that re-sequencing and I have no question to ask you about it, but it's a simple fact and there was no obvious explanation for it. I don't think that it could be called FUD to point that out, but that's not my assessment to make.
Prurisol actually received fewer mentions than Kevetrin in this 10-Q and fewer mentions than it received in the prior 10-Q. Too simplistic? Of course it is. FUD? Can't be....it's true.
"Question #1, do you think the short and distort tactic was and still is being used in IPIX?"
Attributing any of the multi-year downward drift of IPIX's share price to "the short and distort tactic" seems silly and unsupportable to me. I think that the problem was and still is a gradual recognition of the truth.
Next question?
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM